Quest Diagnostics
DGX
#960
Rank
โ‚น2.452 T
Marketcap
โ‚น22,224
Share price
-0.55%
Change (1 day)
52.22%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2026 (TTM): โ‚น819.41

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น874.63. In 2025 the company made an earnings per share (EPS) of โ‚น846.02 an increase over its 2024 EPS that were of โ‚น742.06.

EPS history for Quest Diagnostics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น819.41-3.14%
2025โ‚น846.0214.01%
2024โ‚น742.062.5%
2023โ‚น723.93-5.83%
2022โ‚น768.76-49.21%
2021โ‚น1,51449.72%
2020โ‚น1,01166.67%
2019โ‚น606.6218%
2018โ‚น514.10-4.26%
2017โ‚น536.9923.19%
2016โ‚น435.89-7.11%
2015โ‚น469.2728.46%
2014โ‚น365.31-31.61%
2013โ‚น534.1360.46%
2012โ‚น332.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น1,084 23.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น67.89-107.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น73.44-108.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น185.80-78.76%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น20.03-102.29%๐Ÿ‡บ๐Ÿ‡ธ USA